Intellia Therapeutics, Inc. (NTLA)
13.85
+0.54
(+4.06%)
USD |
NASDAQ |
May 06, 16:00
13.90
+0.05
(+0.36%)
After-Hours: 04:54
Intellia Therapeutics Free Cash Flow : -395.86M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Recursion Pharmaceuticals, Inc. | -328.08M |
| KalVista Pharmaceuticals, Inc. | -- |
| Beam Therapeutics, Inc. | -360.05M |
| Novavax, Inc. | -97.62M |
| Tango Therapeutics, Inc. | -139.93M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -69.28M |
| Cash from Investing (Quarterly) | 27.53M |
| Cash from Financing (Quarterly) | 1.977M |
| Free Cash Flow Per Share (Quarterly) | -0.5988 |
| Free Cash Flow to Equity (Quarterly) | -64.77M |
| Free Cash Flow to Firm (Quarterly) | -69.41M |
| Free Cash Flow Yield | -26.38% |